Maria Roussou Selected Research

Maria Roussou Research Topics

Disease

32	Multiple Myeloma 03/2024 - 04/2007
15	Immunoglobulin Light-chain Amyloidosis 11/2023 - 10/2007
6	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019 - 03/2009
5	Residual Neoplasm 12/2021 - 10/2019
5	Paraproteinemias (Monoclonal Gammopathy) 01/2021 - 10/2011
5	Neoplasms (Cancer) 01/2019 - 04/2009
4	Renal Insufficiency (Renal Failure) 05/2016 - 04/2007
3	Infections 09/2023 - 10/2019
3	COVID-19 09/2023 - 01/2021
3	Amyloidosis 10/2019 - 06/2012
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2017 - 07/2012
2	Disease Progression 01/2021 - 12/2018
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2019 - 10/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2017 - 01/2016
1	Hemorrhage 02/2024
1	Thrombosis (Thrombus) 02/2024
1	Pain (Aches) 09/2023
1	Plasma Cell Neoplasms 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Kidney Diseases (Kidney Disease) 10/2020
1	POEMS Syndrome (Syndrome, POEMS) 01/2020
1	Hypercalcemia (Milk Alkali Syndrome) 01/2020
1	Constipation 10/2019
1	Exanthema (Rash) 10/2019
1	Diarrhea 10/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Leishmaniasis 01/2018
1	Proteinuria 01/2018
1	Monoclonal Gammopathy of Undetermined Significance 01/2018
1	Osteonecrosis (Kienbock's Disease) 10/2017
1	Carcinogenesis 07/2017
1	Wounds and Injuries (Trauma) 01/2016

Drug/Important Bio-Agent (IBA)

16	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 04/2007
15	Lenalidomide (CC 5013)FDA Link 03/2024 - 07/2010
15	Bortezomib (Velcade)FDA Link 12/2021 - 04/2007
6	daratumumabIBA 11/2023 - 01/2018
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 04/2007
5	Monoclonal AntibodiesIBA 09/2023 - 03/2009
4	belantamab mafodotinIBA 01/2024 - 01/2021
4	carfilzomibIBA 01/2021 - 02/2017
4	Immunoglobulin M (IgM)IBA 01/2020 - 01/2018
3	Neutralizing AntibodiesIBA 09/2023 - 01/2021
3	Nerve Growth Factor (NGF)IBA 12/2021 - 01/2021
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 06/2020
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 08/2010
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2016
2	CreatinineIBA 02/2024 - 05/2008
2	VaccinesIBA 09/2023 - 01/2021
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 07/2023 - 08/2022
2	BNT162 VaccineIBA 08/2022 - 01/2021
2	Diphosphonates (Bisphosphonates)IBA 01/2020 - 01/2019
2	Cell-Free Nucleic AcidsIBA 01/2020 - 12/2018
2	Immunomodulating AgentsIBA 12/2019 - 01/2018
2	Melphalan (Alkeran)FDA LinkGeneric 10/2019 - 10/2007
2	Chemokine CCL3IBA 01/2018 - 02/2011
2	LigandsIBA 01/2018 - 02/2011
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 07/2012
2	Rituximab (Mabthera)FDA Link 09/2015 - 03/2009
2	Proteasome InhibitorsIBA 05/2008 - 10/2007
2	Thalidomide (Thalomid)FDA Link 04/2007 - 04/2007
1	AlbuminsIBA 02/2024
1	cilgavimab and tixagevimab drug combinationIBA 09/2023
1	AntibodiesIBA 09/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	tixagevimabIBA 09/2023
1	cilgavimabIBA 09/2023
1	B-Cell Maturation AntigenIBA 07/2023
1	molnupiravirIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Ritonavir (Norvir)FDA Link 01/2023
1	nirmatrelvirIBA 01/2023
1	ATP dependent 26S protease (26S proteasome)IBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	Urokinase Plasminogen Activator ReceptorsIBA 10/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2020
1	pomalidomideIBA 12/2019
1	Drug CombinationsIBA 10/2019
1	Dihydrotachysterol (AT 10)IBA 10/2019
1	ParaproteinsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Growth Differentiation Factor 15IBA 01/2018
1	RANK LigandIBA 01/2018
1	Zoledronic Acid (Zometa)FDA Link 10/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2017
1	Platelet-Derived Growth FactorIBA 07/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2017
1	fludarabineIBA 01/2017
1	Immunoglobulin FragmentsIBA 01/2017
1	ofatumumab FDA Link 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	Cystatin CIBA 01/2016
1	von Willebrand FactorIBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	AntigensIBA 01/2016
1	Lipocalin-2IBA 01/2016

Therapy/Procedure

17	Therapeutics 03/2024 - 10/2011
2	Stem Cell Transplantation 11/2010 - 10/2007
1	Drug Tapering 10/2019
1	Salvage Therapy 12/2018
1	Aftercare (After-Treatment) 01/2017